Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Abstract: Cancer classification plays a very important role in personalized medicine and targeted therapy. To classify the kinds of cancer based on the gene expression data, three different kinds of ...

How do you like your Christmas lights? We all have our preferences, and we’re spoiled for choice, making it easy to decorate our trees exactly the way we want. You can pick white lights, multi-color ...

A dog trainer has shared her simple yet effective method for getting curious and excited pups to stay away from Christmas trees this December. Taking to TikTok,. a dog trainer under the username ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Christmas tree supply is expected to remain steady. With the most wonderful time of the year around the corner, it may be worth it to consider buying a real tree to hide presents under this year. With ...

Saddle systems improve every year. What once seemed like a niche piece of gear that lived in the periphery of more mainstream whitetail hunting alternatives, saddle hunting is the beneficiary of the ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Welcome to this afternoon session with Recursion. My name is Andrew Pucher. I'm part of the Healthcare Investment Banking team, and I'm joined by Ben Taylor, CFO of Recursion; and Sara Sherman, Head ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...